Back to Search
Start Over
Chimerix reports Q2 EPS (16c), consensus (17c)
- Source :
- The Fly. August 10, 2020
- Publication Year :
- 2020
-
Abstract
- Reports Q2 revenue $1.4M, consensus $1.06M. Mike Sherman, Chief Executive Officer of Chimerix, commented, 'Our enthusiasm for the potential of dociparstat sodium to treat COVID-19 patients continues to grow as [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.632094874